Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. (Q45738898)

15 December 2017

title

Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. (English)

1 reference

15 December 2017

0 references

1 reference

S K Pierce

1 reference

15 December 2017

M L Dykstra

1 reference

15 December 2017

R Longnecker

series ordinal

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

page(s)

57-67

1 reference

Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Signal transduction by the B cell antigen receptor and its coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

A role for lipid rafts in B cell antigen receptor signaling and antigen targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

The Immunoreceptor Tyrosine-Based Activation Motif of Epstein–Barr Virus LMP2A Is Essential for Blocking BCR-Mediated Signal Transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Membrane microdomains and caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Membrane rafts and signaling by the multichain immune recognition receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

T cell-dependent B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

The B-cell antigen receptor complex: structure and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Initiation and processing of signals from the B cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Mutations of immunoglobulin transmembrane and cytoplasmic domains: effects on intracellular signaling and antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Functional rafts in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Signaling through the B cell antigen receptor regulates discrete steps in the antigen processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

Capture and processing of exogenous antigens for presentation on MHC molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900089-9

7 January 2021

10.1016/S1074-7613(01)00089-9

Identifiers

DOI

1 reference

15 December 2017

1 reference